Molecular analysis of hprt mutations induced by chromium picolinate in CHO AA8 cells

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 610, Issue 1-2, 2006, Pages 114-123

  Coryell, Virginia H ^a   Stearns, Diane M ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

Author keywords

Chinese hamster ovary; Chromium picolinate; Genotoxicity; hprt; Mutational spectrum

Indexed keywords

ACETONE; CHROMIUM PICOLINATE; DIMETHYL SULFOXIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; SOLVENT; TIOGUANINE;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG SAFETY; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENOTOXICITY; MOLECULAR DYNAMICS; MOLECULAR GENETICS; MUTAGENIC ACTIVITY; MUTAGENICITY; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACETONE; ANIMALS; CHO CELLS; CHROMIUM COMPOUNDS; CRICETINAE; CRICETULUS; DIMETHYL SULFOXIDE; DNA; DNA MUTATIONAL ANALYSIS; DNA, COMPLEMENTARY; EXONS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MUTATION; PICOLINIC ACIDS; SOLVENTS;

CRICETULUS GRISEUS;

EID: 33749250186     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2006.06.020     Document Type: Article

References (52)

1. H. Boynton, G.W. Evans, Chromium picolinate treatment, US Patent 5,087,624 (1992).
2. Nielsen F.H. Controversial chromium: does the superstar mineral of the mountebanks receive appropriate attention from clinicians and nutritionists?. Nutr. Today 31 (1996) 226-233
3. Mirasol F. Chromium picolinate market sees robust growth and high demand. Chem. Market Rep. 257 (2000) 26
4. Pittler M.H., Stevinson C., and Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomized trials. Int. J. Obes. 27 (2003) 522-529
5. Hasten D.L., Rome E.P., Franks B.D., and Hegsted M. Effects of chromium picolinate on beginning weight training students. Int. J. Sport Nutr. 2 (1992) 343-350
6. Hallmark M.A., Reynolds T.H., DeSouza C.A., Dotson C.O., Anderson R.A., and Rogers M.A. Effects of chromium and resistive training on muscle strength and body composition. Med. Sci. Sports Exerc. 29 (1996) 992-998
7. Kaats G.R., Blum K., Fisher J.A., and Adelman J.A. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr. Ther. Res. 57 (1996) 747-756
8. Grant K.E., Chandler R.M., Castle A.L., and Ivy J.L. Chromium and exercise training: effect on obese women. Med. Sci. Sports Exerc. 29 (1997) 992-998
9. Kaats G.R., Blum K., Pullin D., Keith S.C., and Wood R.A. Randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr. Ther. Res. 59 (1998) 379-388
10. Walker L.S., Bemben M.G., Bemben D.A., and Knehans A.W. Chromium picolinate effects on body composition and muscular performance in wrestlers. Med. Sci. Sports Exerc. 30 (1998) 1730-1737
11. Campbell W.W., Joseph L.J., Davey S.L., Cyr-Campbell D., Anderson R.A., and Evans W.J. Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men. J. Appl. Physiol. 86 (1999) 29-39
12. Joseph L.J.O., Farrel P.A., Davey S.L., Evans W.J., and Campbell W.W. Effect of resistance training with or without chromium picolinate supplementation on glucose metabolism in older men and women. Metabolism 48 (1999) 546-553
13. Livolsi J.M., Adams G.M., and Laguna P.L. The effect of chromium picolinate on muscular strength and body composition in women athletes. J. Strength Cond. Res. 15 (2001) 161-166
14. Volpe S.L., Huang H.W., Larpadisorn K., and Lesser I.I. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J. Am. Coll. Nutr. 20 (2001) 293-306
15. Lee N.A., and Reasner C.A. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diab. Care 17 (1994) 1449-1452
16. Ravina A., Slezak L., Mirsky N., Bryden N.A., and Anderson R.A. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diab. Med. 16 (1999) 164-167
17. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., and Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 (1997) 1786-1791
18. Bunker V.W., Lawson M.S., Delves H.T., and Clayton B.E. The uptake and excretion of chromium by the elderly. Am. J. Clin. Nutr. 39 (1984) 797-802
19. Anderson R.A., and Kozlovsky A.S. Chromium intake, absorption and excretion of subjects consuming self-selected diets. Am. J. Clin. Nutr. 41 (1985) 1177-1183
20. Offenbacher E.G., Spencer H., Dowling H.J., and Pi-Sunyer F.X. Metabolic chromium balances in men. Am. J. Clin. Nutr. 44 (1986) 77-82
21. M. McCarty, High-dose chromic picolinate treatment of type II diabetes, US Patent 6,329,361 (2001).
22. Stearns D.M., BelBruno J.J., and Wetterhahn K.E. A prediction of chromium(III) accumulation in humans from chromium dietary supplements. FASEB J. 9 (1995) 1650-1657
23. Borguet F., Wallaeys B., Cornelis R., and Lameire N. Transperitoneal absorption and kinetics of chromium in the continuous ambulatory peritoneal dialysis patient-an experimental and mathematical analysis. Nephron 72 (1996) 163-170
24. Speetjens J.K., Collins R.A., Vincent J.B., and Woski S.A. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem. Res. Toxicol. 12 (1999) 483-487
25. Stearns D.M., Wise Sr. J.P., Patierno S.R., and Wetterhahn K.E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 9 (1995) 1643-1648
26. Stearns D.M., Silveira S.M., Wolf K.K., and Luke A.M. Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutat. Res. 513 (2002) 135-142
27. Manygoats K.R., Yazzie M., and Stearns D.M. Ultrastructural damage in chromium picolinate-treated cells: a TEM study. J. Inorg. Biochem. 7 (2002) 791-798
28. Slesinski R.S., Clarke J.J., San R.H.C., and Gudi R. Lack of mutagenicity of chromium picolinate in the hypoxanthine phosphoribosyltransferase gene mutation assay in Chinese hamster ovary cells. Mutat. Res. 585 (2005) 86-95
29. Gudi R., Slesinski R.S., Clarke J.J., and San R.H. Chromium picolinate does not produce chromosome damage in CHO cells. Mutat. Res. 587 (2005) 140-146
30. Hepburn D.D.D., Xiao J., Bindom S., Vincent J.B., and O'Donnell J. Nutritional supplement chromium picolinate causes sterility and lethal mutations in Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3766-3771
31. Whittaker P., San R.H., Clarke J.J., Seifried H.E., and Dunkel V.C. Mutagenicity of chromium picolinate and its components in Salmonella typhimurium and L5178Y mouse lymphoma cells. Food Chem. Toxicol. 43 (2005) 1619-1625
32. Xu Z., Yu Y., Schwartz J.L., Meltz M.L., and Hsie A.W. Molecular nature of spontaneous mutations at the hypoxanthine-guanine phosphoribosyltransferase (hprt) locus in Chinese hamster ovary cells. Environ. Mol. Mutagen. 26 (1995) 127-138
33. Coryell V.H., and Stearns D.M. Molecular analysis of hprt mutations generated in Chinese hamster ovary EM9 cells by uranyl acetate, by hydrogen peroxide, and spontaneously. Mol. Carcinog. 45 (2006) 60-72
34. Zar J.H. Biostatistical Analysis. 2nd ed. (1984), Prentice-Hall, Inc., Englewood Cliffs, NJ pp. 52-53
35. Snedecor G.W., and Cochran W.G. Statistical Methods. 7th ed. (1980), Iowa State University Press, Ames, IA pp. 208-210
36. O'Neill J.P., Rogan P.K., Cariello N., and Nicklas J.A. Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum. Mutat. Res. 411 (1998) 179-214
37. Sanderson C.J. The uptake and retention of chromium by cells. Transplantation 21 (1976) 526-529
38. Yu Z.W., and Quinn P.J. Dimethyl sulphoxide: a review of its applications in cell biology. Biosci. Rep. 14 (1994) 259-281
39. Bagchi D., Bagchi M., Balmoori J., Ye X., and Stohs S.J. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate. Res. Commun. Mol. Pathol. Pharmacol. 97 (1997) 335-346
40. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., and Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 180 (2002) 5-22
41. Hepburn D.D.D., Burney J.M., Woski S.A., and Vincent J.B. The nutritional supplement chromium picolinate generated oxidative DNA damage and peroxidized lipids in vivo. Polyhedron 22 (2003) 455-463
42. Kato I., Vogelman J.H., Dilman V., Karkoszka J., Frenkel K., Durr N.P., Orentreich N., and Toniolo P. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil. Eur. J. Epidemiol. 14 (1998) 621-626
43. Witmer C., Faria E., Park H.S., Sadrieh N., Yurkow E., O'Connell S., Sirak A., and Schleyer H. In vivo effects of chromium. Environ. Health Perspect. 102 Suppl. 3 (1994) 169-176
44. Breen A.P., and Murphy J.A. Reactions of oxyl radicals with DNA. Free Radic. Biol. Med. 18 (1995) 1033-1077
45. Shibutani S., Takeshita M., and Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation damage base 8-oxodG. Nature 349 (1991) 431-434
46. Duart V., Muller J.G., and Burrows C.J. Insertion of dGMP and dAMP during in vitro DNA synthesis opposite an oxidized form of 7,8-dihydro-8-oxoguanine. Nucl. Acids Res. 27 (1999) 496-502
47. Sugden K.D., Campo C.K., and Martin B.D. Direct oxidation of guanine and 7,8-dihydro-8-oxoguanine in DNA by a high-valent chromium complex: a possible mechanism for chromate genotoxicity. Chem. Res. Toxicol. 14 (2001) 1315-1322
48. Henderson P.T., Delaney J.C., Gu F., Tannenbaum S.R., and Essigmann J.M. Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry 41 (2002) 914-921
49. Kornyushyna O., Berges A.M., Muller J.G., and Burrows C.J. In vitro nucleotide misinsertion opposite the oxidized guanosine lesions spiroiminodihydantoin and guanidinohydantoin and DNA synthesis past the lesions using Escherichia coli DNA polymerase I (Klenow fragment). Biochemistry 41 (2002) 15304-15314
50. Henderson P.T., Delaney J.C., Muller J.G., Neeley W.L., Tannenbaum S.R., Burrows C.J., and Essigmann J.M. The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo. Biochemistry 42 (2003) 9257-9262
51. Davies M.J., Phillips B.J., and Rumsby P.C. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C. Mutat. Res. 290 (1993) 145-153
52. An J., Trieff N.M., and Hsie A.W. PCR-directed DNA sequencing of "nondeletion" HPRT-mutants induced by bleomycin in CHO K1-BH4 cells. Environ. Mol. Mutagen. 32 (1998) 244-250